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1 INTRODUCTION 
 
1.1 Background 
 
The preparation of a marketing plan for a business is a vital help in overseeing the 
marketing strategies for their products. The marketing plan works as an instrument for 
the management to follow if the agreed upon strategies are being implemented. It also 
gives the management something to compare the results to after a certain amount of 
time. (I-trepreneur 2008). 
 
The thesis highlights the company Oriola-KD’s product line called Pharmacare. Oriola-
KD is a Finnish pharmaceutical retail and wholesale company. Oriola-KD has been 
looking for possibilities for growth abroad and in 2008 they branched out to Russia. In 
2012 the Pharmacare product line will be launched in the Moscow region market. The 
region consists of the capital of Moscow itself and the surrounding area called Moscow 
oblast. The Pharmacare product line consists of various quality products that include 
basic wound care, cooling products treatment and personal well-being products. The 
thesis will not focus on all of the products that are in the Pharmacare line, instead the 
focus is on thermometers, cooling products, plasters and bandages.  
 
Pharmacare products are sold widely in Finland as low-end products in pharmacies and 
bigger supermarkets and they have been successful. Oriola-KD already has products in 
the Moscow region that have performed well in Finland, but are not selling as planned 
in Russia. Implementing a marketing plan can help find the strengths and weaknesses of 
selling the product in the Moscow market and helping in understanding the market and 
its consumers. (Bixhelp 2009). 
  
To create a marketing plan, literature within marketing and strategy will be studied and 
evaluated. The price of Pharmacare products in Finland and the prices of its competitors 
in Russia will be compared. A marketing plan will then be conducted based on the best 
strategies for the market. Oriola-KD’s own database will give important and useful 
information about various aspects that will help write the marketing plan. The 
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marketing plan will be reviewed and potentially some or all of the strategies in it will be 
taken into practice by Oriola-KD. 
 
Myriad marketing plans have been written in the past as thesis studies. Marketing plans 
differ, so the use of these studies as references will not be applicable because the 
variation between products, times or places in the study can change the direction of the 
marketing plan completely. For this reason it is essential that a marketing plan be 
written to accommodate the specific needs of Oriola-KD’s product line Pharmacare in 
the Moscow region market. 
 
1.2 Aim of thesis 
 
A marketing plan is essential, when conducting business abroad. The thesis will contain 
a marketing plan for the Pharmacare product lines launch in pharmacies in the Moscow 
region. The empirical part of the thesis will motivate the decisions made in the 
marketing plan. The aim of the thesis is to be a guide that will be used by Oriola-KD for 
this purpose. There are differences in the current environments of where Pharmacare is 
sold compared to Moscow region. The company has committed to launching the 
product line in the Moscow region. Now the step is to find out the social and cultural 
factors that might influence the success of selling the product as well as the local 
availability alternative products from competitors and the difference in purchasing 
power of locals. (Unzco 1998). 
 
Ideally the marketing plan will make the transition to the Moscow region market as 
uncomplicated as possible. A composed plan helps to demonstrate the possible 
advantages and disadvantages the product line has when expanding to the foreign 
market. It requires less effort to forget or overlook a plan that is not written down and 
thus not carrying through with it. A composed plan makes it less difficult to have 
misunderstandings in communication and in what is required from the management. 
(Unzco 1998). 
 
The desired outcome of the result of the thesis is to have a plan that can be executed.  
The research task was how to create an effective marketing plan and what it entails. The 
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thesis should aid in introducing the Pharmacare product line in to the Moscow region 
market. Mullins defines a marketing plan as a “written document detailing the current 
situation with respect to customers, competitors, and the external environment and 
providing guidelines for objectives, marketing actions, and resource allocations over the 
planning period for either an existing or a proposed product or service”. (Mullins.J 
&Orville W & Laréché J-C 2005:20) 
 
“The planner is attempting to manage the future by deciding what to do about the 
possible different trading environments. To best anticipate, influence and exploit future 
markets requires dedicates marketing planning” (Ryals, L 2000:231). 
 
1.3 Structure of the thesis 
 
At the beginning of the thesis there is an introduction and a short description of Oriola-
KD, Pharmacare product line and the situation of the Moscow region market. The 
author carries on to theories that are implicated in the different parts of the actual 
marketing plan. The results of the research will be applied in the marketing plan that 
will be the next and central part of the thesis. The marketing plan will consist of five 
parts: 
 An executive summary 
 An estimation of the current situation. It will be a summary of the competition, 
the potential customers, the Moscow environment that influences the sale of the 
products, an analysis of the strengths and weaknesses of the product line (this 
section typically also includes forecasts estimates of sale potential, and other 
assumptions underlying the plan, which are especially important for proposed 
new products or services. Based on these analyses, the manager may also call 
attention to several key issues-major opportunities or threats that should be dealt 
with during the period. 
 A marketing strategy 
 Implementation controls 
(Kotler & Keller 2009a:96-97)   
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The empirical part of the thesis will follow in the manner of motivating the reasoning in 
the choices made in the marketing plan for the company. The thesis will conclude with 
a discussion relating to the thesis and marketing plan. 
 
1.3.1 Limitations 
 
The limitations in the thesis were that the case company did not have a clear budget for 
the Pharmacare product line in the Moscow region.  Without a budget, financial 
projections cannot be conducted. The second limitation was that the research is not 
conducted only taken in mind the specific parapharmaceutical market due to the scarcity 
of information.  Information has been gathered in regards to the pharmaceutical market 
and the pharmaceutical market. In the authors opinion it gives a valid perception of the 
situation that Pharmacare product line faces.  
 
2 COMPANY BACKGROUND 
 
2.1 General 
 
Oriola-KD is Finland’s second largest pharmaceutical distributor.  Their partners 
include pharmacies, convenience stores, hospitals, pharmaceutical companies, 
veterinarians, healthcare shops and staff. 
Oriola-KD principals consist of over 100 pharmaceutical manufacturers such as 
Janssen-Cilag, Roche, AstraZeneca, Orion Pharma and Boehringer-Ingelheim.  
Oriola is part of the Oriola-KD group which turnover for 2011 was 2.15 billion Euros. 
Oriola-KD employs 4850 people of which 420 work in pharmaceutical whole sales. 
(Oriola-KD 2012). 
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2.1.1 Brief history 
 
The history of Oriola-KD begins with the establishing of KD which stands for Kronans 
Droghandelin 1907 in Gothenburg, Sweden. Oriola Oy was founded in Finland in 1948 
as part of the Orion Corporation. The Finnish Orion Corporation acquired the majority 
of KD in 2002. In 2006 Oriola-KD was detached from Orion and was listed in the 
Helsinki Stock Exchange. Operations in the Baltic countries began in the early 1990’s 
and in Russia in 1996. (Oriola-KD 2011b).  
 
2.1.2  Pharmacare 
 
Pharmacare is a product line that consists of several home first aid supplies. These are 
for example plaster, bandages, thermometers, cooling products, antiseptic gels and 
medicine dispensers. In this thesis the focus will only be on bandages, plaster, cooling 
products and thermometers. (Pharmacare 2012a).  
 
2.2 Market review 
 
Oriola-KD operates in a market whose market value is 16 billion euros. The market 
consist of  Finland, Sweden, Russia and the Baltic countries. Oriola-KD’s turnover in 
2011 was 2.15 billion euros. The turnover for the years first three quarters was 1.58 
billion euros. From this, 49% of the revenue was generated from the Swedish market, 
31% from the Russian market, and 18% from the Finnish market and hence 2% was 
generated from the Baltic market.  (Oriola-KD 2011c; Oriola-KD 2012). 
Based on market share Oriola-KD was the second largest compared to local similar 
companies in Finland and Sweden. In Russia Oriola-KD has a relatively small portion 
of the market share with 7% of the commercial market. (Oriola-KD 2011c). 
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Table 1. Oriola-KD pharmaceutical market (Oriola-KD 2011d) 
Country Market 
position      
Market share Size of pharma market 
Finland No. 2 46 % EUR 2 billion 
Sweden No. 2 40 % EUR 3 billion 
Russia No. 6 7 %,commercial market EUR 10 billion 
Baltic countries - 5-10 % EUR 1 billion 
 
2.2.1 Finland 
 
Oriola-KD is one of the two leading pharmaceutical wholesalers operating in Finland.  
Parapharmaceutical products are products that contribute positively to your health, but 
are not categorized as medicine. The distribution in Finland uses a single-channel 
distribution channel in which the manufacturers of the products concentrate their 
distribution to a single wholesaler. At the end of 2010 there were about 800 pharmacies 
in Finland. 80 percent of sales consisted of prescription pharmaceuticals, 10 percent 
consisted of over-the-counter pharmaceuticals and 7 percent of the pharmacies’ turnover 
consisted of sales of traded goods. (Oriola-KD 2011c). 
 
2.2.2 Russia 
 
Russia has the largest market of the 16 billion euro pharmaceutical markets that are in 
Oriola-KD’s area of operations. Russia’s market value of it is 10 billion euros. In Russia 
the whole sales distribution operates using a multi-channel model, where the 
pharmaceutical manufacturers distribute to multiple wholesalers.   
Oriola-KD operates in Russia as a wholesaler and a retailer. In the Moscow region 
Oriola-KD is the second largest distributor to pharmacies. As a pharmaceutical 
wholesaler Oriola-KD’s wholesale company is the sixth largest in Russia. (Oriola-KD 
2011c). 
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The retail and wholesale sales in 2011 was 689.4 million euros and the operating loss 
excluding non-recurring items was 12.6 million euros. The Russian pharmaceutical 
market grew by 12.4 percent and at the same time Oriola-KD's net sales increased by 
24.9 percent in Russian. (Oriola-KD 2012). 
 
2.2.2.1 Moscow region 
 
Moscow has a population of 10.5 million people and over 20% of Russia’s GDP is 
generated from the city. The official average salary is about 1070 euros per month, 
which is almost twice the amount of the national average of 560 euros. Moscow 
accounts for 17% of all retail sales and a Russia-based expert rating stated that Moscow 
offers the most favorable potential for investment in Russia. (BOFIT Weekly 2010). 
Moscow’s surrounding region is called Moscow oblast. Its population is 7.1 million 
people. (Gks 2010). 
 
2.2.2.2 Retail 
 
Oriola-KD owns over 249 pharmacies in the Moscow region. 181 pharmacies operate 
with the name “Stary Lekar” and 68 operate with name “03 Apteka”. (Oriola-KD 2012).  
Oriola-KD’s objective is to become profitable in the pharmacy business in the Moscow 
region. Growth will be pursued by establishing a stronger market position in the 
Moscow region. Their aim is to gradually add to the product range one of which will be 
the Pharmacare product line in 2012. 
 
2.2.2.3 Wholesale 
 
Oriola-KD’s wholesale company is the sixth largest in Russia with 7 percent market 
share. Oriola-KD’s market position is especially strong in the Moscow region. Oriola-
KD’s pharmaceutical wholesales company operates under the name OOO Oriola. 
(Oriola-KD 2011e). 
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3 LITERARY REVIEW 
3.1 Basis for the marketing plan 
 
By conducting a marketing plan a company establishes prerequisites for accomplishing 
basic marketing tasks. These tasks are for example: creating and fulfilling demand and 
building and developing customer relationships. 
 
Marketing planning must be a continuous and systematic activity. Its aim is to make 
reaching marketing objectives possible. An applicable and carefully thought out 
marketing planning process will help in targeting, distribution and scheduling various 
tasks.  
 
There is no one fixed approach in which the marketing should be planned. The planning 
process is influenced by the industry, company size, by the market itself and by 
experience in planning. The plan is intended to influence the future course of events in 
such a way that benefits the company as well as possible. (Rope & Vahvaselkä 
1994:24−26; Anttila & Iltanen 2001:344; Vahvaselkä 2004:116.) 
  
A marketing plan is needed to determine the course of the company’s brand and 
product. A good plan clarifies the work process and the division of labor. A marketing 
plan is more limited than the extensive business plan that focuses on all the activities of 
the company. The company's marketing plan portrays the company's position in the 
market now and then. It defines the marketing opportunities and threats as well as 
provides clear and realistic objectives. The marketing plan determines the strategy 
needed to achieve the company’s objectives as well as the budget, schedule and control 
measures. (Kotler 2003a:114-117). 
 
3.1.1 Situation Analysis 
 
It is useful for the company to conduct a situation analysis so that the company can 
adequately answer the consumers’ needs. The analysis aids the company to 
acknowledge its internal and external position. (NetMBA 2010). 
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With situational analysis the company analyses macro forces, the environment and the 
parties that affect the company in the situation the marketing plan is conducted for. The 
macro forces consist of socio-cultural, political-legal and technological aspects. The 
parties consist of the company, competitors, distributors and the suppliers. A TOWS 
analysis provides the external information. The TOWS analysis consists of the same 
elements as the SWOT analysis which are: strengths, weaknesses, opportunities and 
threats. The difference is that in the TOWS analysis the emphasis is on external factors 
and the ordering happens from the outside, whereas in the SWOT analysis the ordering 
is from the inside out. (Kotler 2003b:112-113) 
The situation analysis examines the current state of the company as well as the factors 
that will affect the company in the future.  The analysis includes important information 
for the company that describes the direction to where the operating environment is 
evolving to and what opportunities and challenges they will bring to marketing. 
(Raatikainen 2004:61). 
 
The company's marketing environment includes the factors and forces that 
impact on the company's markets and marketing. The marketing environment 
affects the ability to develop and maintain successful transactions as well as 
good relationships with target customers. The marketing environment can be divided 
into the microenvironment and the macro-environment. The company's macro-
environment consists of a more extensive array of social factors that affect the micro-
environment.  
 
3.2 Macro-environment 
 
The macro-environment refers to the company’s operational environment that the 
company itself cannot influence. Macro-environmental factors contribute to the 
opportunities and threats that the company faces and they are largely similar for all 
companies in the industry. (Armstrong & Kotler 2008:67; Anttila & Iltanen 2001:67). 
 
Environmental factors can be grouped into a framework known as the PESTE analysis, 
which stands for: political, economic, social, technological and environmental factors. 
(Kamensky 2000:115).  According to Bergström and Leppänen (2004:83) a macro-
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environment analysis also includes demographic factors as well as international factors. 
A macro-environment analysis presents the following points: 
 demographic factors: size, distribution and structure political factors: political 
environment, legislation, regulations, rules, EU decisions 
 economic factors: income levels and its changes, business cycles, inflation, 
changes in the structure of consumption, availability of labor, labor costs, 
willingness to invest 
 the social and cultural factors: basic values, beliefs, norms, customs 
 technological factors: technology development, inventions, innovations 
 ecological factors: natural resources, climate, consumer values, 
environmental legislation 
 international factors: multiculturalism, globalization, global competition 
(Bergström & Leppänen 2004:83−89; Raatikainen 2004:62). 
 
3.2.1 Segmentation 
 
Segmentation refers to the dividing of the market into clearly distinguishable parts 
based on the customers’ needs and purchasing behaviors. The purpose is to divide the 
customers into groups that have similar needs within the group. The aim of 
segmentation is to find target groups that deliver the best results possible corresponding 
to the company’s resources and know-how.  
 
Segmentation does not by itself produce success for the company; it merely improves 
the company's efforts to manage its customers. (Rope 1998:57). 
 
3.2.2 Market Demographics  
 
A company itself cannot produce value to the customer. It needs other micro-
environmental factors to be successful. Micro-environment factors are close to the 
company and affect its ability to serve its customers. These factors consist of the 
company itself, suppliers, customers, competitors and other stakeholders. (Armstrong & 
Kotler 2008: 64−65). 
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3.2.3 Geography 
 
The term geographics refers to where people live. The variables in geographic 
segmentation are to do with location. These are such as countries, cities, regions and 
streets. (Proctor, T. 2003:87).  
The company may agree to work in various geographic segments or they may 
concentrate on just one or two segments. (Kotler 1991:268). 
 
3.2.4 Demographics 
 
Markets are made up of people. For this reason population is an environmental aspect 
that is of interest to the company. (Kotler 1991:135). 
Breaking down the market into segments is the principal of demographic segmentation. 
Variables used are often such as age, income, nationality, sex and education. The 
buyer’s wants and preferences are frequently in a marked degree correlating to these 
variables. For this reason they are favored by market researchers. (Kotler 1991:269). 
 
3.2.5 Behavior Factors 
 
Behavior segmentation is based on factors that respond to questions on how a product 
makes the customers behave. These factors are such as attitude, response to a product, 
attitude. (Kotler 1991:272).  
 
3.3 Market Needs 
 
When purchasing a product the customer does not want to buy a product. They want to 
meet a need they have. Based on the needs of the customer the company establishes 
their product range and communicates it to the customers. (Doyle 1994:43).   
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The customers’ needs can be provoked by an internal or external stimulus. Internal 
stimuli are basic needs that people have. These are for example hunger, the need for 
shelter and sex. These types of needs can be stimulated to a more elevated level with 
internal stimuli to make the needs become a drive. External stimuli may also be used to 
stimulate the customer’s needs by using advisements and word-to-mouth 
communication. (Armstrong & Kotler 2001:194). 
 
3.4 Market Trends 
 
Analyzing the market trends gives a valuable component to the external analysis of the 
company. Examining market trend has two underlying features. The focus is on change 
and it has a tendency of recognizing significant issues. (Asker & McLoughlin 2010:72). 
 
3.5 Market Growth 
 
A growing market benefits the company. While not increasing the market share, a 
company can increase their profit and sales. The company should be aware of possible 
risks in the market and what forces drive the market.  By analyzing historical material 
the company can discover what has affected the market in the past and attempt to 
forecast the future from that, but concurrently acknowledge that incidental variation or 
short term conditions might be the explanations for growth in the market (Petshnig 
2008:28).  
 
3.6 SWOT Analysis 
 
The SWOT analysis is an examination of the strengths, weaknesses, opportunities and 
threats that a company has. It is suggested in a column by Sarah Simoneaux and Chris 
Stroud called “Business best practices: SWOT Analysis: The Annual Check-Up for a 
Business” that a SWOT analysis is conducted in combination with the original inception 
of a marketing plan for a launch of a new product line. A SWOT analysis encourages 
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adjusting to situations preeminently rather than as a response to already existing 
condition. (Simoneaux & Stroud, 2011:75) 
 
3.6.1 Strengths and Weaknesses 
 
The evaluation of the company’s strengths and weaknesses comprise of an examination 
of internal aspects of the company such as their resources, ability to perform, 
competence and structure. The strengths ought to recognize positive attributes that 
provide the company favored position in comparison to its competitors. Aspects that 
lead to negative outcomes, if not revised, can be considered as weaknesses. 
 
The aim is to retain and work on the strengths to further improve the company and to 
maintain and leverage strengths in ways to benefit the company and to establish which 
weaknesses require fixing in pursuance of enhancing the position of the company. 
(Simoneaux & Stroud, 2011:75-77) 
 
3.6.2 Opportunities and Threats 
 
An evaluation of the company’s opportunities and threats gives a look to the external 
forces that possibly affect the company. These forces can be such as laws and 
regulations, political conditions, technology, competition, situations in the industry and 
the market. 
 
The opportunities in the SWOT analysis characterize possibilities, where the company 
can achieve growth in performance of profitability. Unlike opportunities, the threats are 
made up of forces that might result in a disadvantageous situation for the company. 
  
A company cannot act on all opportunities and threats so the company should evaluate 
carefully which are the most crucial strategies for a favorable outcome. (Simoneaux & 
Stroud, 2011:75-77). 
17 
 
 
3.7 Competition 
 
The company must know how to define and identify the competitors that are companies 
in the same line of business and in the same market segment. (Raatikainen 2004:64). 
 
To achieve a relative advantage or competitive edge the company needs to have 
extensive knowledge of the dynamics of competition and of the current competitor’s 
goals and strategies. It needs to understand the possibility of alternative products and 
future prospects in the market. (Kamensky 2000:133). 
 
The critical flaws in drafting a competitor analysis are that the company has established 
too narrow borders for the industry and the lack of identifying a competitor. In 
identifying the competition first and foremost the obvious question is which companies 
are the key competitors. According to Pirttilä 2000:25−26) there are two main 
competitor definitions that are used to defined competitors: a market-based and 
industry-based definition. 
  
The industry-based definition means that that the companies compete with each other,  
when they have a similar technology and similar products. This limits the competitors to 
companies within the same industry. When competing within the same market, the 
companies’ products fulfill the same needs of the customers and so they can substitute 
one another. This definition is broader than the first and it exceeds industry lines. 
Raatikainen states that (2004:64) the elements that are taken into account in the 
competitor-analysis are: 
 The size and names of the companies 
 Competing products 
 Competitive measures used by competitors 
 Competitors’ market position 
 Characteristics of competition 
 Notoriety of competitor  
 Competitors financials 
 Competitors marketing strategy 
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The most straightforward variant of competition is brand competition.  In addition, 
competition can exist among alternatives and brands of product types. Companies do 
not typically compete directly with every company in the industry. For that reason it is 
imperative to recognize the companies that can be distinguished as key competitors.  An 
analysis of key competitors generally includes these aspects: 
 An assessment of every competitor’s strengths. 
 Current market share and former trends 
 Financial strengths and management competence 
 Technical and operating benefits 
(Cravens 1991:145-146). 
 
3.8 Marketing Strategy 
 
Marketing strategy is concerned with strategic and operational marketing issues that 
arise in response to continuing growth in trade. It also involves the availability of new 
products and services, the dramatic increase in mobile foreign investment, the 
widespread move of people and the pervasiveness of international competition at the 
level of the firm. (Bradley 2005:29).    
Marketing strategies should build an advantage over competitor’s principle of 
marketing. (Ferrell & Hartline 2010:47). Marketing strategy is inherently people-driven 
and it is never stagnant. It is about people finding ways to deliver exceptional value by 
fulfilling the needs and wants of other people (customers, shareholders, business 
partners) as well as for the needs of the organization itself. (Ferrell & Hartline 2010:15). 
 
3.8.1 Mission 
 
The company’s primary reason for existing should be indicated in the mission. It states 
what the company is, its values and the consumers it hopes to attend to. It supplies the 
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management with indication on how to cultivate their strategies onwards. (Berkowitz 
2010:43). 
 
3.8.2 Marketing Objectives 
 
Realistic and specific marketing objectives should be established by the management. 
They should be coinciding with overall goals and objectives of the company. The 
objectives should be possible to measure. Otherwise it becomes difficult to know if the 
strategy achieved its goal. (Haas 1992:316).     
 
3.9 Target Markets 
 
Defining the target market accurately is essential for the company. It is easier to 
produce a product that some will than a product that everyone will want.  Consequently 
the company defines and forms specific groups who may favor or desire or require 
certain product mixes by analyzing psychographic, behavioral and demographic 
differences between customers. The company then determines the segment that offers 
the best potential for profit. The segments are the target segments. (Kotler & Kevin 
2009b:29). 
 
3.10 Positioning 
 
Positioning a product successfully can contribute by placing it in a diacritic and 
desirable spot in the minds of the customers the company wants to target.  The 
positioning aims to differentiate the product from its competitors and thus give an 
advantage. The company will have to determine if they are going to have one or 
multiple differentiating factors for the product. Once the desired position has been 
established the company has to communicate the chosen position to the target 
customers. (Armstrong & Kotler 2011:234; Kotler 2003b:122). 
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3.11 Strategies 
   
The strategy is a plan of the organization's activities and events. It comprises of 
thoughts, choices and actions with what the company aims to achieve the goals that 
have been defined in their vision. The company's marketing strategy is an operational 
action plan that the company uses to work towards achieving its strategic marketing 
visions in practice and providing value to customers and owners, but also to other 
network partners. (Tikkanen, Aspara & Parviainen 2007:57−60). 
 
Competitive strategy refers to a search in the industry for a favorable competitive 
position for the company. With a competitive strategy the company aims to achieve a 
viable and permanent position against the forces that define the competition within the 
industry. A pivotal part of a competitive strategy is the question of competitive 
advantage. (Porter 1991:13; Kamensky 2000:199). 
 
The company has three generic competitive strategies to work with. The strategies are, 
cost leadership, differentiation and market segmentation. Marketing segmentation has a 
further two options: cost leadership and differentiation based strategy. The choice of 
which strategy to choose is affected by the market scope of the target market and the 
choice between uniqueness, competency and low cost competency. (Porter 1991:25). 
 
A company that chooses to go with a cost leadership strategy aims to offer the lowest 
prices in the target market. Cost leadership typically sells a standard product and 
focuses on the advantages it receives - economies of scale or the absolute costs. In order 
to succeed in the business the company will need to maintain its prices at mid-range or 
close to it. In addition, the product must be equivalent or at least comparable with its 
competitor’s product. When executing a differentiation strategy the company justifies 
its higher price point on the fact that they offer something that adds value to the product 
which makes the customer willing to pay more. Differentiation can be based on the 
product, the product distribution system, marketing or various other factors. A company 
that chooses to follow a segmentation strategy by determining a segment or segments, 
and constructs its strategy that serves the targeted segments. (Porter 1991:25−28; 
Kamensky 2000:216). 
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According to Armstrong and Kotler (2008:527) the content for a marketing strategy 
depends on the company's market position. On the other hand Bergström and Leppänen 
(2004:76) state that companies may also have a variety of competitive roles with which 
they aspire to survive in the market. Based on Kotler (2003a:254) the company's role 
may be the market leader, the challenger, a follower or a niche marketer. 
 
The market leader in its segment has the largest market share; it has a good image and 
well-known products. The market leader’s strategies are market growth by defending 
and increasing market share. The challenger is a company with a highly visible and 
often aggressive marketing practice. The challenger tries to increase its market share by 
attacking other companies. Suitable challenger attack strategies are for example price 
reduction, product profiling or improving service. The follower generally does not have 
the resources to compete and for a company with a follower strategy it may be more 
profitable to imitate a competitor’s product rather than increasing cost with innovation. 
A niche marketer is a company that invests in an original and narrow market niche. The 
company selects a small segment of the market, which by focusing on it can achieve a 
good status in this target group. (Kotler 2003a:269; Bergström & Leppänen 
2004:75−77). 
 
3.12 Marketing Mix 
 
The marketing mix is a set group of functions and linked tools implemented by the 
company to provoke consent of the products services and intentions. When evaluating 
the optimum marketing mix for a product you encounter a multitude of different 
options. This is where you have to take a strategic focus to narrow down the 
alternatives. (Dalrymple & Parsons 1995:12). 
 
The four P marketing mix was introduced by Edmund McCarthy in 1960. It has been 
used for the marketing of tangible products. The four Ps of marketing are: 
 Product. The product has to be what the customers expect it to be. It should 
carry out the function that it promises to do.  
 Place. The product should be sold in locations where the target segment would 
expect to find it in.  
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 Promotion. All tools of communicating the company’s message of the product 
should be within the parameter of the area of advertising for the companies 
target group of customers and the message should be appealing to that group.  
 Price. The product should exhibit good value for money. If the product works 
well the customer may be willing to pay more. Price does not always mean that 
the cheaper the product is the more appealing it is for the consumer. (Blythe, 
2008:9-10). 
 
3.12.1 Product 
 
A product may be anything that satisfies a possible want or need and that can be offered 
in the market. Marketable products can be physical goods, services, experiences, events,  
places, properties, organizations, information and ideas (Kotler 2003a:407). According 
to Mäntyneva (2002:52) the product is the central competitive factor in marketing, 
because the existence of the product brings forth the possibility for applying other 
completive factors. 
Kotler (2003a:407) states that there are five levels that increase the value of a product 
for the customer. These values form a customer’s value hierarchy. 
The innermost layer is the core benefit which means the very fundamental service or 
benefit that the customer is really buying.  In the second levels is the company's need to 
convert the core benefit in to a basic product, which is the physical product or the 
service. 
 A third level is composed of the expected product that is the set of characteristics and 
circumstances that the customer typically expects to receive when they purchase the 
product. The fourth level is the augmented product with which a marketer strives to 
exceed the customer’s expectations. This level is currently where a bulk of the 
competition occurs however every augmentation adds costs and quickly stops being a 
change expected by the customer. The fifth level holds all possible differentiation and 
augmentations that the product may be subjected to in the future. In this level the 
company looks for new ways to serve its customers and distinguish themselves from 
their competition. (Kotler 2003a:408). 
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3.12.2 Price 
 
The price serves multiple functions in achieving commercial success. The price 
measures and generates the value of the product; it is a basic element in competition and 
positioning. Price competition parameters consist of the price and price variations as 
well as discounts and payment terms. (Rope 1998:93−94). 
 
A number of factors affect the price of the product (Mäntyneva 2002:92). The company 
needs to be familiar with their costs, so that they will be able to price their products 
profitably. The competitive situation affects pricing, because when competition 
increases so does the supply of the market thus causing the prices to decrease. The entry 
of new competitors may drop the prices at least temporarily. Product properties have a 
significant impact on pricing. Standard products, which are identical to competing 
products, have a low price range. The pricing range can be broadened by adding 
differentiating characteristics to the product.  
 
The target groups impact the pricing of the product. This implies that the company is 
capable of selling the same product at different prices to different customers. In some 
industries government regulation may affect pricing significantly, although a growing 
number of industries have moved up to compete freely. Lastly the available resources 
affect the company’s capacity to produce a product of a service. (Mäntyneva 
2002:96−98). 
 
The company has three general pricing methods from which to choose from. These are 
cost-based, competition-based and value-based pricing. Cost-based methods are for 
example cost-plus pricing, target profit pricing and break-even pricing. Cost-plus 
pricing is the easiest method. It is adding a fixed mark-up to the cost of the product. 
When defining a price for break-even or for a target profit, the company predetermines 
a profit percentage, which they want to achieve. 
 
Value-based pricing is establishing the price based on how the customer perceives the 
value of the product instead of the basing it on the seller’s cost. (Armstrong & Kotler 
2004:357-361). 
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3.12.3 Place 
 
Place refers to the actions the company takes to make their product available to the 
target groups. (Armstrong & Kotler 2008b:50). 
 
The company has three possible distribution channel systems: a direct marketing 
channel, an indirect marketing channel and a multichannel system. In the direct 
marketing channel the company sells its product straight to the customer without 
intermediaries. Direct marketing is often more preferable to the indirect marketing 
channel when the need for information is high, quality or the customization of the 
product is important of when transportation and warehousing of the product is difficult. 
Direct marketing is often more preferable to the indirect marketing channel. (Armstrong 
& Kotler 2004:400-408). 
 
Direct marketing channels provide the company with the most control over the 
customer relationships as direct marketing channels allow for instant customer service 
with the customer. Direct marketing channels consist of face-to-face selling, 
telemarketing, television and other media, online marketing catalogs and direct-mail 
marketing. The challenges for direct marketing channels are the lack of resources or 
lack of expertise. (Kotler 1999:533; Kotler 1999:725). 
 
In the indirect distribution channel the product reaches the customer through 
intermediaries. The benefit of it is the relatively cheaper price, which makes it possible 
for the company to attend to the needs of customers, who do not buy small amounts. 
The indirect channel is applicable when multiple product purchases at one time and 
accessibility are important. Indirect marketing channels are more complicated than 
direct channels due to the fact that they include external parties. 
 
The company does not receive full control on what the distribution channel offers the  
customers. The distribution channel may also include competing products. The 
existence of intermediary companies between the company and the end users also filter 
out market information, which the company could take advantage of, for example in 
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product development. In some cases, the best option is to use direct and indirect 
channels in combination, for example if the company sells its products outside its home 
market. (Mäntyneva 2002:137−138; Lehmann & Winer 2003:404-406). 
 
3.12.4 Promotion 
 
Promotion helps to point out information that should influence the target group to carry 
out the desired purchase decisions. Promotion contains all possible communication that 
should provide positive interaction among the company and the customer. Promotion 
covers a wide range of methods and functions and also a large number of target groups. 
Promotion is the most visible of all marketing activities and often a significant amount 
of, money, time and human labor are invested in it. The most important means of 
promotion are advertising and personal selling. In addition there are other possibilities 
with which the company can affect the promotion objectives. (Vuokko 2003:17−19; 
Isohookana 2007:90-91). 
 
3.13 Marketing Research 
 
All the companies that operate in a market economy are affected by various aspects of 
market. Understanding the nature and intensity of the market forces will help businesses 
to adapt to the macro environment and to control their operations in it.  (Beljavski 
2004:8).  
 
In order to succeed in the market the company will need to have current information 
about the market. The company needs to monitor market developments, so that it is able 
to predict possible market changes and adapt to them. The company receives needed 
information by performing market research (Soimakallio 1995:9-10). Marketing 
research offers information concerning the market, the consumers, the distributers, the 
competitors, and other elements of the company’s environment. Marketing research 
aims to determine the need for information and subsequently provide the management 
with all the necessary information they need to base their marketing decisions. The 
obtained data is used to identify and define the opportunities and problems and to 
create, refine and evaluate marketing efforts. (Mäntynevä, Heinonen & Wrange 2008:9).  
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International market information regarding the global environment is however more and 
more unstable and less predictable. An increasing variety of things should be taken into 
account in a single target market. In addition, with globalization, competition will 
intensify considerably, which will lead to an increasing need of market information. 
(2001 Vaarnas &Virtanen: 23). 
 
3.14 Financials 
 
The financial projections include a break-even analysis, a sales forecast and an expense 
forecast. On the revenue side, the projections show the forecast sales volume by month 
and product category. On the expenses side, they show the expected costs of marketing, 
broken down into finer categories. The break-even analysis shows how many units the 
firm must sell monthly to offset its monthly fixed costs and average per-unit variable 
costs. (Brady, Goodman, Hansen, Keller, Kotler 2009:110). 
 
3.14.1 Break-Even Analysis 
 
To help the company establish how many goods they should sell to cover their 
expenses, a break-even analysis can be conducted.  The break-even point is when the 
company’s total sales equal total costs. The break-even point is the point at which total 
revenue equals total cost. (Boone & Kurtz 2011:626). 
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3.15 Controls 
 
The marketing plans final segment features the controls for keeping track and adapting 
the implementation of the plan. Generally they define the budget and the goals for 
upcoming months. This allows the management to assess each period and if necessary 
they can alter their strategies. It is possible to incorporate contingency plans in the case 
of having to respond to environmental changes. These may be such circumstances as 
price wars or workers strikes. (Boone & Kurtz 2011:626-627). 
 
3.16 Summary 
 
The empirical part of the thesis consists of the marketing plan for Oriola-KD’s product 
line Pharmacare in the Moscow region. Oriola-KD is planning on launching the product 
line in 2012, which presented the need for a marketing plan. 
  
The target company decided to expand its product range in the Moscow region with the 
Pharmacare product line, and the Oriola-KD determined that a marketing plan should be 
created. The situation analysis is based on knowledge acquired from marketing 
literature as well as information acquired from the target company’s web pages. The 
competitor names required for the competitor analysis were attained by visiting 
pharmacies in the Moscow region in Russia as well as scanning Russian pharmacies’ 
websites. 
 
The SWOT analysis was drawn up based on the situation analysis and the latest 
available financial statement. The most appropriate strategy was chosen based on or the 
theoretical options presented in the literary portion of the thesis.  
The competitive action plan and the follow-up were based on marketing literature 
reflected on in the theory part of the thesis and then analyzed based on the authors best 
ability to produce a viable solution for the target company. 
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4 MARKETING PLAN 
 
4.1 Situation Analysis 
 
The starting point for the micro-environment analysis includes the basis for the 
marketing plan, an analysis of the company, suppliers, distribution channel members, 
and customer and competitor analyses. Macro-environment analysis examines Oriola-
KD’s external environment. Finally, a starting point for analysis should be based on the 
assessment of the company's strengths, weaknesses, opportunities and threats in the 
SWOT analysis. 
 
4.2 Market Summary 
 
Moscow is the center of international trade and the economic and political center in 
Russia. A large number of Russian corporate headquarters are located in the capital. 
Moscow's economy relies heavily on trade and services. The largest industry sectors in 
Moscow are the building machinery, food processing, oil and chemical industries. 
Moscow has market potential in virtually every field, and the market is also expected to 
grow further in the future. When considering the total population, it is important to note 
that in addition to the officially registered, there are about two million inhabitants, who 
are not registered in the city. In addition, two million additional people arrive to work in 
the city from all over Russia, Belarus and Ukraine. (Tiri 2007:56-57; Gks 2010) 
 
Moscow has an official population of 10.5 million people and. (BOFIT Weekly 2010). 
Moscow’s surrounding region is called Moscow oblast. Its population is 7.1 million 
people and covers an area of 46 058 km ². Moscow oblast has 74 cities. The largest 
cities in the oblast are Elektrostal, Lyubertsy, Kolomna, Podolsk and Mytishchi. (Gks 
2010) The total population of the Moscow region is 16.1 million people. 
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4.2.1 Geography and demographics 
 
Oriola-KD has set the Moscow region i.e. the city of Moscow and surrounding Moscow 
oblast as its geographic target area in Russia. In the next few years Russia's economy is 
projected to grow more than 4% and inflation should slow down, which means that the 
GDP per capita will continue to grow, and the Russian inhabitants’ average standard of 
living will improve. (Bank of Finland 2010).  
Moscow's economic growth has exceeded the average in growth compared to other 
areas of Russia throughout the last ten years. The capital has the lowest unemployment 
rate in the country. The average monthly salary in Moscow 2010 was 1070 € which is 
almost twice the national average of 560 €. (BOFIT 2010). 
 
“Russian purchasers are generally sophisticated and highly educated. They are likely to 
be internet users and receptive to imported goods. Russian purchasers may be price 
sensitive, but are frequently willing to pay for quality, especially for recognized and 
reliable imported brands – another reason to invest in advertising” (US commercial 
service 2012:17). 
 
Private consumption will remain a key factor in Russian production and imports in the 
forecast period. According to consumer confidence indicators, the financial situation is 
expected to improve but the pace has leveled in recent years. Consumption is expected 
to grow slightly this year and the following years. (BOFIT 2012:2) 
 
Russia’s economic growth is forecasted to grow in 2012-2014 by about a pace of 3.5 
percent and Russia’s imports are forecasted to increase by about 7% a year. Private 
consumption and investment are expected to drop somewhat this year due to external 
and internal uncertainties and they are expected to pick up again next year. Towards the 
end of the forecast period, economic growth is projected to slow down, because the 
price of oil is not expected to rise. (BOFIT 2012:3). 
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4.2.2 Behavior Factors 
 
Consumers who are willing to pay more for a good product and who might prefer a 
Western product are the people who are likely to respond to the product line. Also 
consumers, who want to ensure that the products are not counterfeit, are people who 
will probably respond positively to the product line. 
 
4.3 Market Needs 
 
Oriola-KD provides a wide range of medical supplies. The company aims to answer the 
need for quality. Oriola-KD wants to provide products of high quality to customers, 
who want value for their money. 
They also wish to have a brand which caters to all the different medical supply needs 
that consumers have, so that the supplies can be purchased from one place and one 
manufacturer. 
 
4.4 Market Trends 
 
Most products in the Pharmacare product line are available already in the market. What 
distinguishes the product line is that all the Pharmacare products are displayed in one 
stand in the pharmacies. The customer can easily find all the products at one location in 
the pharmacy while the other competing products are all located in separate places in 
the pharmacy.  
The Pharmacare product line also includes cooling products that are not supplied widely 
in Moscow region pharmacies. This is seen as a fine opportunity for Oriola-KD, 
because that gives them an advantageous situation with no competition. 
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4.5 Market Growth 
 
According to the Russian Pharma Sector Forecast for 2013, the para-pharmaceutical 
market will grow with a compound annual rate growth of 13% during 2011-2013. 
(Rncos 2011).  
 
4.6 SWOT Analysis 
 
The SWOT analysis has been constructed based on Oriola-KD's strengths, weaknesses,  
opportunities and threats in the parapharmaceutical market. 
 
The analysis does not explain the situation in the company with regards to the company 
as whole. It focuses on issues that pertain to the launch of the product line in Moscow. 
The analysis is compiled from the possible strengths and weaknesses that emerged in 
the initial situation analysis. It also contains opportunities and threats that the 
company’s external environment has created. 
 
The SWOT analysis gives input on the chances of the product line’s survival in the new 
market. 
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Table 2. Pharmacare SWOT Analysis 
 
4.6.1 Strengths 
 
The company's strengths consist of the broad selection of quality products and the way 
they are presented in the pharmacies. The broad selection of products makes it possible 
to reach more consumers with different needs that contribute to a larger consumer base. 
Oriola-KD has their own set on pharmacies in the Moscow region that will ease the 
distribution of the product.  
 
Within the product line it can be considered strength that there is a selection of cooling 
products that otherwise is not well represented in the Moscow market.  
Strengths  
 Finnish products have a good 
reputation in Russia 
 The company owns pharmacies in 
Moscow 
 Very few  cooling products in the 
market 
 
 
Weaknesses 
 The existence of cheaper products 
in the market 
 Brand not known currently in 
Russia 
 
Opportunities 
 A large market offers potential for 
large profits 
 Large sales can lower production 
costs 
Threats 
 Competition and pricing 
 Corruption 
 Bureaucracy restrictions 
 Commitment of key personnel 
 Fluctuations in the ruble 
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4.6.2 Weaknesses 
 
There is a large amount of completion in the market for almost all of the products. It 
will be a challenge to stand out.  The brand is not known currently in Russia and this is 
a risk factor for the company.  
The simultaneous opening of new pharmacies with tight competition will have an 
impact on Oriola-KD's pharmaceutical business profitability in Russia. Changes in the 
Russian ruble exchange rate will increase the customer’s credit risk and cause a possible 
change in the competitive situation and this may have an impact on the profitability of 
wholesale trade in Russia. (Oriola-KD 2012). 
 
4.6.3 Opportunities 
 
There are a number of opportunities in the marketplace. The Moscow region market is 
the largest market where Pharmacare is sold. This gives potential for large sales that 
could lead to a larger profit. If the product succeeds, the company can gain a better 
margin through economies of scale. 
 
4.6.4 Threats 
 
A downturn in the economy may have an adverse effect on people spending their 
income on more expensive products.  
The forecast for Russia's economy is for the most part negative. Even if the world 
economies would decline less than anticipated, the still relatively high degree of 
confidence of Russian consumers may be affected negatively. (BOFIT 2012). 
 
Based on a study by AEB (Association of European Businesses), foreigners consider 
corruption and bureaucracy to be the biggest obstacles for trade and investment in 
Russia. Additional challenges rise from the large amount of existing legislation and tax 
law as well as their interpretation. 
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The activities of Russian authorities complicate normal business transactions, financial 
management and long-term planning. Despite the new competition law reform in Russia 
the bureaucracy and corruption are increasing. (Granholm 2010:13). 
 
4.7 Competition 
 
The competitor analysis examines the market and competitive situation of Oriola-KD's 
competitors. The data in the analysis is based on company websites as well as visits to 
pharmacies in the Moscow region. The analysis focuses on parapharmaceutical market 
competitors. Oriola-KD's key competitors are examined more thoroughly utilizing the 
competitors’ company websites, whilst the more marginal competitors are examined 
more generally. 
 
The parapharmaceutical industry is competitive. There are many companies that offer 
similar products to what is included in the Pharmacare product line. The competitors of 
Pharmacare are basically all industry-based. The competitors offer similar products and 
technology. Even though there is little market-based competition, there are several other 
products in the same industry. These competitors can be divided into core and marginal 
competitors. 
 
Pharmacare offers a various different products. In the marketing plan the products are 
limited to plasters, bandages, thermometers and cooling products. 
 
The key competitors of the Pharmacare product line are: 
Thermometer market: Omron, AAD, Med, tvu 120, Little Doctor, Microlife 
Plaster market: Sarepta-mediplast, Ukraine, Veropharm, Russia, Pharmline Ltd, 
UK/Everaid Co Ltd, South Korea, Laboratoires Urgo, France, P.Hartmann, Germany, 
Johnson&Johnson, USA (made in France), Plastod, Italy, Pharmaplast, Egypt 
Bandige market: Rostbiomed, Kiev-Guma, Ugro, Fari-sfera OOO, Leiko, Tonus, 
Appolo 
Cooling products market: Trichema AG, Switzerland and Müller/USA. (See Appendix 
1for competitors). 
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4.8 Marketing Strategy 
 
The key to the marketing strategy is to achieve visibility in the pharmacies that sell the 
Pharmacare product line. There is a huge deal of competition for the all the products 
except for the cooling products. It will be important that all of the products are stocked 
at all times, so that the brand can establish itself as having all the products in one place, 
and that the consumer can visit the Pharmacare stand and locate all needed products 
there. The more the products are purchased the more the knowledge of the brand will 
spread and this may account for enlarging the segment to whom the product appeals.  
 
4.9 Mission and vision 
 
Oriola-KD has a mission that they describe with the slogan: "The Channel for Health".  
Oriola-KD is a leading pharmaceutical retail and wholesale operator to pharmaceutical 
companies and consumers in northern Europe and Russia. Oriola-KD's mission and 
vision was determined in 2010. The mission and vision highlight the fact that the 
company wants to be the most preferred partner and channel in northern Europe and 
Russia between the pharmaceutical industry and the consumer by providing reliable 
access to the market for manufacturers and providing consumers with excellent and 
reliable service. (Oriola-KD 2011g). 
 
4.10 Marketing Objectives 
 
Penetrating the market successfully is the objective for Oriola-KD. This can be achieved 
by forming a recognizable and positive brand image to the distributor and consumer. 
When customers have a positive image the sales can begin growing at a steady pace.  
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4.11 Target Markets 
 
The target markets are mainly the “Stary Lekare” and “Apteka 03” pharmacies in the 
Moscow region. After time the product line can be also sold in other pharmacies as well 
as well-equipped convenience stores. 
 
4.12 Positioning 
 
The Pharmacare product line will be positioned as a higher end product line. It will not 
be able to compete with the cheapest products on price, but it is competitive with the 
other high-end foreign and domestic products.  
 
4.13 Strategies 
 
Oriola-KD should acquire awareness for their new product line. This can be achieved by 
having the product line’s products on a unique stand in pharmacies. Other competitors 
are displayed on the shelves and in different spots dedicated to that particular medical 
supply. Plasters are placed next to other plasters, and so on. Pharmacare products will 
all be displayed in one place so that the customer can see the whole array of products in 
one glance without having to go around the whole pharmacy. This will show the 
customer the large selection of products and it gives an image of being in a class of its 
own and thus of higher quality.   
 
The second step would be to begin providing the Pharmacare product line to well-
equipped convenience stores and other pharmacies. This will be possible after gaining 
more awareness for the brand. 
 
The message that Oriola-KD wishes to convey is that it offers products appealing to the 
eye and that its products give value for money. 
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4.14 Marketing Mix 
 
The marketing mix describes the current marketing factors that the Pharmacare product 
line has in the Moscow region. 
 
4.14.1 Product   
 
The Pharmacare product line offers a vast array of medical products. There are fifteen 
different types of products and each type has different versions of the products, which 
vary in size and price. In the marketing plan the focus is on four products. 
The first products are plasters. There are seven types of plaster in Pharmacare’s product 
portfolio that vary from plastic plaster to waterproof plasters. 
The second products are bandages. There are four different types of bandages: elastic, 
non-elastic and a highly elastic bandages as well as an adhesive bandage.  
The third products are thermometers. There are two different thermometers: A basic 
digital thermometer and a digital thermometer that has a flexible tip. 
The fourth products are cooling products. There are three different cooling products: a 
cold gel, an instant cold pack and cold-hot pack. 
 
4.14.2 Price   
 
Russian consumers are interested in bargains, but are increasingly willing to pay for 
quality merchandise. Consumers in Russia are attracted to bargains, but they are also to 
a greater extent capable and ready to spend their earnings on quality goods. (US 
commercial service 2012:17).  
A comparable pricing strategy would be most suitable for the Pharmacare product line. 
The pricing strategy consists of pricing the products comparably to the product 
selections of the competitors. The market leaders have already produced a perception of 
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the price for the customers. Thus the company then compares its prices to the products 
available. 
 
4.14.3 Place 
 
Oriola-KD has purchased a chain of pharmacies in the Moscow area called “Stary 
Lekar” and several other pharmacies. The product line would be initially sold in these 
pharmacies. The pharmacies are spread throughout the Moscow region (See Appendix 2 
and 3). Pharmacies run online shops and the product will be sold there as well. 
 
4.14.4 Promotion  
 
Russia’s e-commerce in 2010 was valued at 9 billion dollars and internet marketing was 
400 million dollars in sales. In the upcoming years internet usage is forecasted to grow 
considerably. (US commercial service 2012, 17).  
 
Pharmacare will be promoted in the “Stary lekar” pharmacies website. The unique 
product stand will be placed in pharmacies, so that the products will be visible to 
incoming customers. 
 
4.15 Implementation and controls 
 
The company will construct a detailed plan to achieve its objectives. 
The company will at least once a year provide answers to the following questions:  
 Where are you? (Progress report)  
 Where do you want to go? (Objectives) 
 How do you get there? (Strategies) 
 When do you want to reach it? (Timetable for implementation) 
 Who is responsible? (Organization and responsibilities) 
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 How much will the measures cost? (Budget) 
(Rope 2005:488-489).  
5. CONCLUSION 
 
Marketing planning is a key element in structuring the company's business plan. The 
tangible end product of planning is a marketing plan, which in this case is used for an 
individual product line in the Moscow region in the Russian Federation. 
The marketing plan is designed to determine the company's product, marketing 
direction and clarify the division of work and the schedule. A good marketing plan is 
simple, precise enough, challenging, realistic, practical and flexible. The objective of 
this study was to develop a marketing plan that will assist in the preparation of 
launching a new product line in the Moscow region for the company Oriola-KD.  
 
The research question was how to create an effective marketing plan and what 
it entails. The theoretical portion of the thesis analyzed the different components of the 
marketing plan that were: the situation analysis, the market analysis, objectives, 
strategy, competition and control.  
A marketing strategy was designed for the target company based on the information 
from the market analysis. The objective is to attain the target group effectively and 
profitably. 
The result of this thesis is a marketing plan for Oriola-KD's Pharmacare product line for 
the Moscow region market in Russia that complies with the theory presented in the 
marketing plan requirements. 
By facilitating the plan, the target company may take the measures set to achieve the 
objectives set for the product line. 
In the opinion of the author the thesis is a success, because it achieved its objectives. 
The choice of the subject for the thesis was interesting and challenging, because the 
Pharmacare product line did not have specific financials established for the Pharmacare 
launch in the Moscow region. Acquiring information of the Moscow region market 
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proved to be more challenging than if the market would have been the local Finnish 
market. That is why the company's marketing had to be investigated broadly and all of 
the marketing plan areas had to be explored. 
However, the author has tried to obtain new workable solutions for the specific product 
line in addition to finding out the purchasing behavior of the target group. The 
marketing plan is flexible and can be changed if new and effective marketing 
opportunities are found later. Oriola-KD should be follow up on feedback from 
customers and keep up with competitors’ actions and their progress, and if necessary, 
modify the market plan. 
In the future, the company can use the marketing plan for the benefit of other products 
or product lines. 
 
 
41 
 
LIST OF REFERENCES   
 
Anttila, M. & Iltanen, K. 2001. Markkinointi, 5
th
 edition. WSOY. 
 
Armstrong, G & Kotler, P. 2001, Principle of marketing, 9
th
 edition. Prentice Hall. 
 
Armstrong, G & Kotler, P. 2004. Principles of marketing, 10
th
 international edition. 
Prentice hall. 
 
Armstrong, G & Kotler P. 2011 Principle of marketing, 11th Global edition. Prentice 
Hall. 
 
Armstrong, G. & Kotler, P. 2008. Principles of Marketing. Pearson International 
Edition. Prentice Hall. 
 
Armstrong, G. & Kotler, P. 2008. Principles of Marketing. 5
th
 European edition. 
Prentice Hall. 
 
Asker, A & McLoughlin. 2010. Strategic Market Management: Global Perspectives, 9
th
 
edition. John Wiley and Sons. 
 
Beljavski, I. 2004. Marketivoja issledovania. Uchebnoe posobi. Rukovodstvo po 
izucheniju disiplinu. Moskova: Moskovan taloustieteen, tilastotieteen ja tietotekniikan 
valtiollinen yliopisto  
 
Bergström, S. & Leppänen, A. 2004. Yrityksen asiakasmarkkinointi, 9th edition. Edita. 
 
Berkowitz, E. 2010. Essentials of Health Care Marketing, 3
rd
 edition. Jones & Bartlett 
Learning.  
42 
 
 
Bixhelp. 2009 Published 2009. 
http://www.bizhelp24.com/marketing/how-can-a-marketing-plan-benefit-your-
business.html. Accessed 19.12.2011. 
 
Blythe, J. 2008. Essentials of marketing, 4
th
 edition. Pearson education. 
 
BOFIT Weekly 2010, Bank of Finland’s Institute for Economies in Transition, No. 42, 
pp.1. http://www.webcitation.org/5tmjrHFzM. Accessed 10.1.2012. 
 
BOFIT 2012. Venäjä ennuste 2012-2014. The Bank of Finland.  
http://www.suomenpankki.fi/bofit/seuranta/ennuste/Documents/bve12012.pdf.  
Accessed 22.3.2012. 
 
Boone, L & Kurtz, D. 2011. Contemporary Marketing, 5
th
 edition. Cengage Learning, 
800 pages. 
 
Bradley, F. 2005, International marketing strategy, 5
th
 edition, Pearson Education. 
 
Brady, M., Goodman, M., Hansen, T,.  Keller, K,. Kotler, P. 2009. Marketing 
management, 1
st
 European edition. Pearson Education. 
 
Intern management group 2002 a. Virtual Internships: real experience in a virtual  
world -a best practice handbook for those interested in the concept of virtual 
internships in business education. Odense: Tietgen Business College, Denmark  
 
 
43 
 
Gks 2010. Vserossijskoij perepisi naselehija 2010 goda. (2010 All-Russia Population 
Census). Federal State Statistics Service. Published 2010. 
http://www.gks.ru/free_doc/new_site/perepis2010/perepis_itogi1612.htm. Accessed 
13.2.2012. 
 
Cravens, D. 1991.Strategic marketing, 3
rd
 edition. Richard Irwin Inc. 
 
Dalrymple, D & Parsons, L. 1995. Marketing management: text and cases, 6
th
 edition. 
Wiley. 
 
Doyle P. 1994. Marketing management and strategy. Prentice Hall international limited.  
 
Ferrell, O & Hartline, M. 2010. Marketing Strategy, 5
th
 edition. Cengage Learning. 
 
Granholm, L. 2010. Venäjän kauppa nousuun. Venäjän aika 2/2008. Helsinki: 
Novomedia Ltd.  
 
Haas, R. 1992. Business marketing management; an organizational approach, 5
th
 
edition. Pws-Kent. 
 
Isohookana, H. 2007. Yrityksen markkinointiviestintä.  Helsinki: WSOY. 
 
I-trepreneur. 2008 Published 2008. 
http://i-trepreneur.com/2008/09/02/importance-of-marketing-plan-in-business/ . 
Accessed 19.12.2011. 
 
Kamensky, M. 2000. Strateginen johtaminen. Kauppakaari. 
44 
 
 
Karlöf, B. 2004. Strategian rakentaminen. Edita. 
 
Kotler, P. 1991. Market management: Analysis, Planning, Implementation, and Control, 
7
th
 edition. Prentice hall. 
 
Kotler, P. 1999. Marketing management analysis, planning, implementation and 
control, 9
th 
edition. Prentice hall. 
 
Kotler, P. 2003a. Marketing management, 11
th
 .edition. Prentice Hall. 
 
Kotler, P. 2003b, Marketing insights from A to Z: 80 concepts every manager needs to 
know. John Wiley sons, Inc.  
 
Kotler, P& Keller. 2009a. Marketing management, 13
th
 edition. Prentice hall. 
 
Kotler P & Keller, K 2009b, A Framework for marketing management, 4
th
 edition, 
Pearson Prentice Hall. 
 
Lehmann, D. & Winer, R. 2003. Product management, 3
rd
 edition. New York: 
McGraw-Hill. 
 
Metsämuuronen, J. 2008. Laadullisen tutkimuksen perusteet, 4
th
 edition. Helsinki: 
International Methelp. 
 
Mullins.J & Orville W & Laréché J-C. 2005, Marketing management: a strategic 
decision-making approach. McGraw-Hill/Irwin series of marketing. 
45 
 
 
Mäntyneva, M. 2002. Kannattava markkinointi. Porvoo: WSOY. 
 
Mäntynevä, M. Heinonen, & Wrange, K. 2008. Markkinointitutkimus. Helsinki: WSOY. 
 
NetMBA 2010, Situation analysis. Published 2010. 
http://www.netmba.com/marketing/situation/. Accessed 14.1.2012. 
 
Oriola-KD. 2011a, Tietoa meistä. Published 2011. 
http://www.oriola.fi/Oriola-lyhyesti/Tietoa-meista/ . Accessed 3.1.2012. 
 
Oriola-KD. 2011b, Historia. Published 2011. 
http://www.oriola.fi/Oriola-lyhyesti/Historia/ Accessed 3.1.2012. 
 
Oriola-KD. 2011c, Markkinakatsaus. Published 2011. 
http://www.oriola-kd.com/Konserni/Markkinakatsaus/ Accessed 3.1.2012. 
 
Oriola-KD. 2011d, Strategia. Published 2011. 
http://www.oriola-kd.com/Konserni/Strategia/ Accessed 3.1.2012. 
 
Oriola-KD. 2011e, Venäjän vähittäis- ja tukkukauppa. Published 2011. 
http://www.oriola-kd.com/Konserni/Liiketoiminta/Venajan-vahittais--ja-tukkukauppa/ /. 
Accessed 11.1.2012. 
46 
 
Oriola-KD. 2012, Tilinpäätöstiedoite. 2011. Published 2012. 
http://www.oriola.fi/Uutiset--Media/Uutiset/Oriola-KD-Oyjn-tilinpaatostiedote-11---
31122011/. Accessed 3.4.2012. 
 
Oriola-KD. 2011f, Vision2011. Published 2012. 
http://www.oriola-kd.com/Konserni/Strategia/Missio/. Accessed 12.1.2012 
 
Petshnig, S.2008. Identify potential countries for a market entry with a sales 
organization: A Guideline for Small and Medium-sized Enterprises. Leeds Metropolitan 
University. 
 
Pharmacare 2012a, Tuotteet. Published 2012. 
http://www.pharmacare.fi/?page_id=6. Accessed 13.1.2012. 
 
Pirttilä, A. 2000. Kilpailijaseuranta, WSOY. 
 
Porter, M. 1991. Kilpailuetu, 3
rd
  edition. Weilin+Göös. 
 
Proctor, T. 2003. Essentials of Marketing Research, 3
rd
 edition. Pearson Education 
Limited. 
 
Raatikainen, L. 2004. Tavoitteellinen markkinointi – markkinoinnin tutkimus ja 
suunnittelu. Edita. 
 
 
47 
 
Rncos, 2011. News wire today. Published 2011. 
http://www.newswiretoday.com/news/105752/ 
 
Rope, T. & Vahvaselkä, I. 1994. Suunnitelmallinen markkinointi. Weilin+Göös. 
 
Rope, T. 1998. Business to business –markkinointi. WSOY. 
 
Ryals, L. 2000. Planning for relationship marketing. Marketing management: a 
relationship marketing perspective. Cranfield School of Management. 
 
Silk, A. 2006. What is marketing? Boston, Massachusetts: Harvard Business 
School Press. 
 
Simoneaux, S. 2011.  Business best practices: SWOT Analysis: The Annual Check-Up 
for a Business. Journal of pension benefit. Vol.18, No 3, pp.75–78 
 
Soimakallio, A. 1995. Markkinatutkimus pk-yrityksessä. Jyväskylä: Gummerus 
Kirjapaino. 
 
Suomenpankki. 2010, Russia. Published 2010. 
 http://www.suomenpankki.fi/en/NR/rdonlyres/A0C226F8-3D3F-4B6F-8AA3-
B621E963D4CC/0/w201042.pdf. Accessed 28.2.2012. 
 
Tikkanen, H., Aspara, J. & Parviainen, P. 2007. Strategisen markkinoinnin 
perusteet, 2
nd
 edition. Talentum.  
 
Tiri, M. 2007. Venäjän liiketoiminnan perusopas. Helsinki: Suomalais-Venäläinen 
kauppakamari. 
 
Unzco 1998, Accessed 18.12.2011. Published 2008 
http://www.unzco.com/basicguide/c2.html 
48 
 
 
US commercial service 2012. Doing Business in Russia: 2012 Country Commercial 
Guide for U.S. Companies. U.S. department of state, United States. 159 pages. 
http://photos.state.gov/libraries/russia/231771/PDFs/2012-ccg-russia.pdf. 
 Accessed 6.3.2012. 
 
Vaarnas, M. & Virtanen J. 2001. Markkinatieto yrityksen kansainvälistymisessä, 2
nd
 
edition. Tampere: Tammer-Paino. 
 
Vuokko, P. 2003. Markkinointiviestintä. Helsinki: WSOY. 
 
 
49 
 
APPENDICES 
Appendix 1. Products available in Moscow pharmacies as of March 20, 2012. 
 
PRODUCTS AVAILABLE IN 
MOSCOW PHARMACIES AS OF 
MARCH 20, 2012 
PIECE
S IN 
PACK 
MANUFACTURER 
PRICE 
(RANGE) 
 
1.Plasters 
 
Water-resistant 24 Sarepta-mediplast, 
Ukraine 
33,50-
53 
Travel set small 14 Sarepta-mediplast, 
Ukraine 
41-82 
Comfort pack 10 Sarepta-mediplast, 
Ukraine 
34-60 
Tourist pack 24 Sarepta-mediplast, 
Ukraine 
38-71 
Economy pack 24 Sarepta-mediplast, 
Ukraine 
41-66 
“Home pharmacy” 30 Sarepta-mediplast, 
Ukraine 
75-99 
“Detskij Mir” (Children’s world) 12 Sarepta-mediplast, 
Ukraine 
45-60 
    
Antiseptic plaster/stripes 24 36,6, Russia 49 
    
Uniplast antiseptic/white 1,9 cm x 7,2 
cm 
8 Veropharm, Russia 39,83-
42,50 
Uniplast antiseptic/body color 1,9 cm 
x7,2 cm 
8 Veropharm, Russia 48-55 
Uniplast antiseptic/body color elastic 1,9 
x 7,2 
8 Veropha”rm, Russia 41-
71,81 
Uniplast antiseptic /invisible elastic 1,9 
x7,2 
8 Veropharm, Russia 52,17 
Uniplast antiseptic water-resistant 
1,9x7,2 
8 Veropharm, Russia 55,20 
Uniplast antiseptic/white 1,9x7,2 20 Veropharm, Russia 61,60 
Uniplast antiseptic/body color fabric-
base 1,9x7,2 
20 Veropharm, Russia 62,50 
Uniplast antiseptic invisible 1,9x7,2 20 Veropharm, Russia 80 
Uniplast antiseptic water-resistant 
1,9x7,2 
20 Veropharm, Russia 75,92 
Uniplast antiseptic (0,95x3,8 №5; 
2,3x7,2№5;2,5x7,2№8;3,8x3,8№2) 
20 Veropharm, Russia 83,25 
Uniplast antiseptic elastic verodamp 
1,9x7,2 
20 Veropharm, Russia 91 
50 
 
Uniplast antiseptic elastic veroflex 
1,9x7,2 
20 Veropharm, Russia 102 
Smart Aquastop 2x7 5 Veropharm, Russia 96 
Smart Aquastop 2x7 8 Veropharm, Russia 127-
149 
    
Antiseptic /white 20 Novosibchempharm, 
Russia 
58,53 
    
Master Uni Travel pack 1,9x7,2 20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni Classic 1,9x5,7 20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni Sensitive polyester cloth-
based 1,9x5,7 
20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni water-resistant 1,9x7,2 №10; 
1,9x5,7 №5; 1x4 №5 
20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
47,60 
Master Uni for kids 1,9x5,7 20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
45 
Master Uni Aqua for kids 1,9x5,7 10 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
66 
Master Uni for kids water-resistant 
Smeshariki 2,7x5,7 
10 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
56,40 
Master Uni Home Pharmacy 1,9x7,2 
№10; 1,9x5,7 №5; 3,8x3,8 №5; plasters 
for fingers polyester cloth-based №3; 
plasters for heel polyester cloth-based 
№2; rolls 2,5 m №2 
26 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni Aqua 2,5x6,3 №10; 3,8x3,8 
№5  
15 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
93,81 
Master Uni First Aid 1,9x7,2 10 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni “Dachnik” (summer 
cottager) 1,9x7,2 №15; 1,9x5,7 №5; 
3,8x3,8 №5; round D 2,2 cm №5 
30 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
 
Master Uni Tourist 1,9x7,2 №10; 
1,9x5,7 №5; 3,8x3,8 №5; plasters for 
fingers polyester cloth-based №5; 
plasters for heel polyester cloth-based 
№5 
25 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
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Master Uni Glance
1
 Classic 2x7 20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
72-110 
Master Uni Glance Sensitive 20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
45,60 
Master Uni Glance Aqua 2x7 15 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
67-110 
Master Uni Glance Marine 3,8x7 5 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
93,50 
Master Uni Glance Purpur (purple) 
polyester cloth-based 1,9x7,2 (for 
sensitive skin) 
20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
72 
Master Uni Glance Silver 2x7 
(antibacterial with silver) 
20 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
110 
Master Uni Glance Gold 1x7,3 (for dry 
corns) 
6 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
110 
Master Uni Glance Marine (for wet 
corns) 
5 Pharmline Ltd, 
UK/Everaid Co Ltd, 
South Korea 
93,50 
 
    
Urgo Aquafilm antiseptic water-resistant 10 Laboratoires Urgo, France 50 
Urgo Aqua 300 Laboratoires Urgo, France 600-
1050 
Urgo elastic 10 Laboratoires Urgo, France 40,40 
Urgo elastic 300 Laboratoires Urgo, France 900-
1200 
Urgo transparent 10 Laboratoires Urgo, France 34-
45,20 
    
Nimplast 1,9x7,2 20 Herbion, Pakistan 35,90-
40,40 
    
Cosmos water-resistant/2 sizes 20 P.Hartmann, Germany 69 
Cosmos water-resistant 6x10 5 P.Hartmann, Germany 61 
Cosmos Kids/2 sizes 20 P.Hartmann, Germany 68-85 
    
Band-Aid antiseptic water-resistant 20 Johnson&Johnson, USA 
(made in France) 
109-
118 
Band-Aid antiseptic absolute comfort 20 Johnson&Johnson, USA 
(made in France) 
80 
Band-Aid Comfort fit Sheer 20 Johnson&Johnson (made 
in France) 
70 
                                                          
1
 Master Uni Glance – product line designed for women 
52 
 
Band-Aid antiseptic elastic 20 Johnson&Johnson, USA 
(made in France) 
101 
    
Luxplast ultra thin hypoallergenic water-
resistant 1,9x7,2 
10 Plastod, Italy 14,60-
27 
Luxplast perforated water-resistant 
transparent 1,9x7,2 
10 Plastod, Italy 11,90-
25 
Luxplast perforated water-resistant body 
color 1,9x7,2 
10 Plastod, Italy 11,80-
22 
Luxplast polyester cloth-based/elastic 
water-resistant body color 
10 Plastod, Italy 12,80-
30 
    
Sanitaplast (set №4)  20 Betasan, Turkey 58,20 
    
Silkoplast antiseptic standard 20 Pharmaplast, Egypt 78,40 
Silkoplast antiseptic universal 20 Pharmaplast, Egypt 60,70-
78,90 
Silkoplast antiseptic sensi 20 Pharmaplast, Egypt 79,50 
Silkoplast Kids 20 Pharmaplast, Egypt 60,70 
    
2.Bandages 
 
Bandage non-sterile 5 m x7cm 1 Nika/Russia 7,30 
Bandage non-sterile 7 m x14 cm 1 Nika/Russia 8 
Bandage non-sterile 5x10 1 KPTF/Russia 14,40 
Bandage non-sterile 7x14 1 KPTF/Russia 14,30-
20 
Bandage non-sterile 7x14 1 36,6/Russia 21,50 
Bandage non-sterile 10x16 1 Medtex/Russia 13,20 
    
Bandage sterile 5x7 1 Pharm-Global/Russia 9,60 
Bandage sterile 5x10 1 Variant/Russia 15,10 
Bandage sterile 5x10 1 Amelia/Russia 16-
18,70 
Bandage sterile 5x10 1 36,6/Russia 13,50 
Bandage sterile7x14 1 36,6/Russia 20 
Bandage sterile7x14 1 Amelia/Russia 16,57-
25,20 
Bandage sterile 10x16 1 Variant/Russia 34,20 
Bandage sterile 10x16 1 Garant/Russia 30,50 
Bandage sterile 10x16 1 Nika/Russia 29 
    
Bandage elastic 3x12 1 Tonus Elast/Russia 129 
Bandage elastic 3x10 1 Lauma/Latvia 165 
Bandage elastic 3x8 1 Tonus Elast/Russia 82,50 
Bandage elastic 2x8 1 Tonus Elast/Russia 76 
Bandage extra elastic 2x8 1 Tonus Elast/Russia 63,5 
Bandage extra elastic with clasp 3x10 1 36,6/Russia 99 
Bandage elastic with clasp 3x8 1 Tonus Elast/Russia 74 
53 
 
Bandage elastic 3x8 1 Lauma/Latvia 159 
    
Bandage extra elastic Peha-Crepp 4x4 1 Paul Hartmann AG, 
Germany 
22,60 
Bandage extra elastic Peha-Crepp 4x4 20 Paul Hartmann AG, 
Germany 
238 
Bandage extra elastic Peha-Crepp 4x6 1 Paul Hartmann AG, 
Germany 
24 
Bandage extra elastic Peha-Crepp 4x6 20 Paul Hartmann AG, 
Germany 
253 
Bandage extra elastic Peha-Crepp 4x8 1 Paul Hartmann AG, 
Germany 
28,60 
Bandage extra elastic Peha-Crepp 4x8 20 Paul Hartmann AG, 
Germany 
302 
Bandage extra elastic Peha-Crepp 4x10 1 Paul Hartmann AG, 
Germany 
32,50 
Bandage extra elastic Peha-Crepp 4x10 20 Paul Hartmann AG, 
Germany 
342 
Bandage extra elastic Peha-Crepp 4x12 1 Paul Hartmann AG, 
Germany 
40,50 
Bandage extra elastic Peha-Crepp 4x12 20 Paul Hartmann AG, 
Germany 
428 
    
Bandage elastic Lastotel 4x4 1 Paul Hartmann AG, 
Germany 
21 
Bandage elastic Lastotel 4x6 1 Paul Hartmann AG, 
Germany 
27 
Bandage elastic Lastotel 4x6 20 Paul Hartmann AG, 
Germany 
387 
Bandage elastic Lastotel 4x8 1 Paul Hartmann AG, 
Germany 
31 
Bandage elastic Lastotel 4x8 20 Paul Hartmann AG, 
Germany 
530 
Bandage elastic Lastotel 4x10 1 Paul Hartmann AG, 
Germany 
37 
Bandage elastic Lastotel 4x12 1 Paul Hartmann AG, 
Germany 
55 
    
Cohesive conforming bandage Peha-
Haft 4x4 
1 Paul Hartmann AG, 
Germany 
78 
Cohesive conforming bandage Peha-
Haft 4x6 
1 Paul Hartmann AG, 
Germany 
90 
Cohesive conforming bandage Peha-
Haft 4x8 
1 Paul Hartmann AG, 
Germany 
109 
Cohesive conforming bandage Peha-
Haft 4x10 
1 Paul Hartmann AG, 
Germany 
123 
    
Cohesive conforming bandage Peha-
Haft latex-free 4x2,5 
8 Paul Hartmann AG, 
Germany 
683 
54 
 
Cohesive conforming bandage Peha-
Haft latex-free 4x4 
1 Paul Hartmann AG, 
Germany 
77 
Cohesive conforming bandage Peha-
Haft latex-free 4x6 
 Paul Hartmann AG, 
Germany 
91 
Cohesive conforming bandage Peha-
Haft latex-free 4x8 
1 Paul Hartmann AG, 
Germany 
111 
Cohesive conforming bandage Peha-
Haft latex-free 4x10 
1 Paul Hartmann AG, 
Germany 
123 
Cohesive conforming bandage Peha-
Haft latex-free 4x12 
1 Paul Hartmann AG, 
Germany 
143 
Cohesive conforming bandage Peha-
Haft latex-free 20x4 
1 Paul Hartmann AG, 
Germany 
306 
Cohesive conforming bandage Peha-
Haft latex-free 20x6 
1 Paul Hartmann AG, 
Germany 
364 
Cohesive conforming bandage Peha-
Haft latex-free 20x8 
1 Paul Hartmann AG, 
Germany 
439 
Cohesive conforming bandage Peha-
Haft latex-free 20x10 
1 Paul Hartmann AG, 
Germany 
540 
Cohesive conforming bandage Peha-
Haft latex-free 20x10 
6 Paul Hartmann AG, 
Germany 
3212 
Cohesive conforming bandage Peha-
Haft latex-free 20x12 
1 Paul Hartmann AG, 
Germany 
681 
    
Bandage elastic 4,5x15 1 Müller/USA 263 
    
Bandage elastic tubular 1 Intex/Russia 5,50 
Bandage elastic tubular 2 Intex/Russia 7,50 
Bandage elastic tubular 3 Intex/Russia 11,50 
Bandage elastic tubular 4 Intex/Russia 12,70 
Bandage elastic tubular 5 Intex/Russia 13,70 
Bandage elastic tubular 6 Intex/Russia 15,90 
    
3.Digital Thermometers 
 
A&D DT-501 1 A&D Company, Japan 
(manufactured in China) 
140-
245 
A&D DT-510 1 A&D Company, Japan 
(manufactured in China) 
170-
260 
A&D DT-621 1 A&D Company, Japan 
(manufactured in China) 
98-181 
A&D DT-622 1 A&D Company, Japan 
(manufactured in China) 
165-
250 
A&D DT-623 flexible 1 A&D Company, Japan 
(manufactured in China)  
164-
251 
A&D DT-625 intelltronics 1 A&D Company, Japan 
(manufactured in China) 
533,60 
A&D DT-633 infrared 1 A&D Company, Japan 
(manufactured in China) 
438-
460 
A&D DT-635 forehead/ear 1 A&D Company, Japan 515-
55 
 
(manufactured in China) 896 
    
AMDT-10  1 Amrus, USA 79,10-
110 
AMDT-11 1 Amrus, USA 100,90-
150 
AMDT-12 1 Amrus, USA 113,82-
133 
AMDT-13 1 Amrus, USA 118,51 
AMDT-14 1 Amrus, USA 112,84 
    
CT-212 1 CBM Corporation, Japan 127 
Citizen CT-461 1 CBM Corporation, Japan 78,30-
130 
Citizen CT-461C 1 Citizen, China 102,50-
130 
Citizen CT-513W waterproof 1 CBM Corporation, Japan 98,10-
125 
Citizen CT-561C 1 Citizen, China 91,84-
128,50 
    
Thermometer-soother for newborns NT-
01C 
1 LEB International, USA 219-
290 
Thermometer-soother for newborns LD-
303 
 Little Doctor 
International, China 
219-
224,10 
    
MT/3001 1 Microlife, Switzerland 103-
185 
MT/16B1 1 Microlife, Switzerland 126-
230 
MT/1931 1 Microlife, Switzerland 191-
340 
MT/1622 1 Microlife, Switzerland 165,70-
288,30 
MT/1671 1 Microlife, Switzerland 104,97-
160 
MT/1751 thermometer-soother for 
newborns  
1 Microlife, Switzerland 285-
485 
MT/1951 1 Microlife, Switzerland 290-
490 
    
WF-1000 infrared 1 B.Well, UK 750-
1022 
WF-2000 infrared forehead 1 B.Well, UK 948-
1515,50 
WT-03 basic 1 B.Well, UK 80-125 
WT-04 standard 1 B.Well, UK 130-
140 
WT-05 accuracy 1 B.Well, UK 165 
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WT-06 flex 1 B.Well, UK 126,50-
265 
WT-07 jumbo 1 B.Well, UK 215-
339,50 
WT-09 quick 1 B.Well, UK 280-
320 
    
Thermoval Basic 1 Hartmann, Germany 94-188 
Thermoval Classic color 1 Hartmann, Germany 250-
340 
Thermoval Rapid  1 Hartmann, Germany 310-
369 
Thermoval Classic Disney 1 Hartmann, Germany 280-
299 
Thermoval Rapid Disney 1 Hartmann, Germany 330 
Thermoval Rapid Kid 10 sec 1 Hartmann, Germany 327 
Thermoval Rapid Flex 1 Hartmann, Germany 310-
402 
    
O-Temp II MC-204E 1 Omron, Holland 172-
220 
ECO-Temp Smart MC-341RU 1 Omron Healthcare, Japan 
(manufactured in China) 
235-
301 
ECO-Temp Basic MC-246RU 1 Omron Healthcare, Japan 
(manufactured in China) 
150-
210 
ECO-Temp MC-203E 1 Omron, Holland 150-
220 
ECO-Temp II MC-241 W-E 1 Omron Healthcare, Japan 
(manufactured in China) 
185-
220 
i-Temp MC-670E 1 Omron Healthcare, Japan 
(manufactured in China 
499-
600 
i-Temp mini MC-271W-E 1 Omron, HealthcareJapan 
(manufactured in China) 
293-
425 
Flex-Temp MC-205E 1 Omron, Holland 280-
360 
Flex-Temp II MC-206-E 1 Omron Healthcare, Japan 
(manufactured in China) 
295-
343,50 
Flex-Temp Smart MC-343F-RU 1 Omron Healthcare, Japan 
(manufactured in China 
275-
349 
Gentle Temp MC-510-E2 1 Omron Healthcare, Japan 
(manufactured in China 
1655-
1995 
    
Digital thermometer flexible 1 36,6/Russia 235 
    
Forehead thermometer infrared BD1100 1 Bremed, Italy 814,80-
850 
Ear thermometer infrared BD1190 1 Bremed, Italy 840-
1270 
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Digital thermometer  Philips Electronics Ltd, 
UK 
1199 
    
Forehead thermometer 820 Thermotek 1 SAAT, Israel 770-
1099 
Forehead thermometer 1 SAAT, Israel 1190 
    
4.Cooling products 
 
Cooling spray Antistax 75 ml 1 Boehringer-Ingelheim, 
Germany 
180-
699 
    
Cooling spray Carmolis 300 ml 1 Trichema AG, 
Switzerland 
333-
497 
Cooling gel Carmolis pro-active 160 ml 
tube 
1 Trichema AG, 
Switzerland 
255-
337 
    
Cold/hot pack 15x22,5 cm 
 
1 Müller/USA 
 
1450 
Cooling gel-pack 15x27 cm, 500 ml 1 Koopman International, 
Holland 
250 
available 
in body 
shops 
only 
Effol Ice-pack instant cooling compress 
15x27 cm 
1  260 
available 
only in 
shops for 
horse-
riding 
equipmen
t 
Instant cold pack disposable Snezhok 1 Fest/Russia 7-10 
Instant cold pack for first aid disposable 1 Appolo/Russia 5-15  
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Appendix 2. Locations of Stary lekar pharmacies in Moscow region. 
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Appendix 3. Locations of 03 Apteka pharmaciesin the Moscow region. 
 
 
 
